Showing results (541-550 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|May 22, 2026
TLR7 induces autophagy in non-small cell lung cancer tumor cells and influences anti-tumors responses in patientsLucas Leonardi, Solenne Marmier, Nathalie Josseaume, et al.
Translational Lung Cancer Research|May 22, 2026
Understanding the dual role of granulocyte-macrophage colony-stimulating factor in the lung cancer tumor microenvironment and its therapeutic implicationsGang Wei, Xuanji Zhu, Rui Zhong
Translational Lung Cancer Research|May 22, 2026
Evaluating the early therapeutic response of radiofrequency ablation in rabbit VX2 lung tumors: a comparison of four diffusion weighted imaging modelsQinqin Yan, Wen Ye, Fei Shan, et al.
Translational Lung Cancer Research|May 22, 2026
Lung cancer associated with cystic airspaces in the perioperative immunotherapy era: radiologic and pathologic pitfalls, surgical extent, and management implicationsXue He, Qi Liu, Weijia Zeng, et al.
Translational Lung Cancer Research|May 22, 2026
Mid-term efficacy and safety of transbronchial cryoablation for stage IA peripheral lung cancer: a retrospective analysisRui Yang, Junxiang Chen, Fangfang Xie, et al.
Translational Lung Cancer Research|May 22, 2026
Occupational physical workload and risk of lung cancer and chronic respiratory diseases: a prospective cohort study of the UK BiobankShuxiao Ma, Yi Liu, Zihuai Wang, et al.
Translational Lung Cancer Research|May 22, 2026
Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trialJianjiao Ni, Zilu Zheng, Xi Yang, et al.
Translational Lung Cancer Research|May 22, 2026
Narrative review of the similarities and differences between immune checkpoint inhibitor- and antibody-drug conjugate-associated pneumonitisRuiting Tan, Fangfei Qian, Yao Zhang, et al.
Translational Lung Cancer Research|May 22, 2026
The resistance landscape of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer: molecular mechanisms and novel therapeutic strategiesShuotong Liu, Linsen Zhou, Yongze He, et al.
Translational Lung Cancer Research|March 11, 2026
Real-world insights into multidisciplinary management and outcomes of stage III (N2-3) non-small cell lung cancerJing-Sheng Cai, Jia-Qi Zhao, Dilimulati Abulizi, et al.
Pageof 240